Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Lisdexamfetamine Dimesylate in Treatment of Cognitive Impairment (Chronic Fatigue Syndrome): A Double Blind, Placebo Controlled Study

NCT01071044 is registered in ClinicalTrials.gov with Rochester Center for Behavioral Medicine as lead sponsor.

NCT NCT01071044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01071044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Lisdexamfetamine Dimesylate in Treatment of Cognitive Impairment (Chronic Fatigue Syndrome): A Double Blind, Placebo Controlled Study
Lead sponsor
Rochester Center for Behavioral Medicine
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2009
Completion date
March 31, 2011
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue syndrome, cognitive impairments